期刊文献+

骨髓增生异常/骨髓增殖性疾病实验室诊断分析 被引量:3

原文传递
导出
摘要 骨髓增生异常/骨髓增殖性疾病(myelodysplastic/myeloproliferative disease,MD/MPD)为克隆性疾病,其临床及血液学表现既有骨髓增生异常综合征(myelodysplastic syndrome,MDS)的病态造血现象,又有慢性骨髓增殖性疾病(chronic myelopmliferave disease,CMPD)的特点。WHO将其归入MD/MPD中,包括慢性粒一单核细胞白血病(chronic myelomonocytic leukemia,CMML),不典型慢性粒细胞白血病(atypical chronic myeloid leukemia,aCML),幼年型粒一单核细胞白血病(jevenile myelomonocytic leukemia,JMML),
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2009年第4期438-440,共3页 Chinese Journal of Laboratory Medicine
  • 相关文献

参考文献7

  • 1卢兴国,马顺高.骨髓增生异常/骨髓增殖性疾病形态学和分子病理[J].检验医学,2005,20(2):165-167. 被引量:6
  • 2Germing U, Gattermann N, Strupp C, et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes:a retrospective analysis of 1600 patients. Leu Res, 2000, 24:983-992.
  • 3Hasle H. Myelodysplastic and myeloproliferative disorder in children. Curt Opin Pediatr, 2007, 19 : 1-8.
  • 4James C, Ugo V, LE Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 2005, 434 : 1144-1148.
  • 5朱平.骨髓增殖性疾病JAK2基因突变的临床意义[J].中华医学杂志,2006,86(32):2243-2245. 被引量:14
  • 6Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005,106 : 2162-2168.
  • 7Jelinek J, Oki Y, Gharibyan V, et al. JAK2 mutation 1849G >T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryoeytic leukemia. Blood, 2005,106: 3370-3373.

二级参考文献26

  • 1Jaffe ES. Harris NL, Sten H, et al. Pathology and genetics of tumours of haematopietic and lymphoid tissues [M]. Lyon:IARC Pess,2001. 45-49.
  • 2Hasle H, Niemeyer CM, Chessells JM. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases[J]. Leukemia,2003,17:277-282.
  • 3Cross NCP, Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases [J]. Leukemia, 2002, 16: 1207-1212.
  • 4Kvasnicka HM. Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders [J]. Pathologe, 2002,23:448 -456.
  • 5Druker B J, Lydon NB. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia[J]. J Clin Inverst,2000,105:3-7.
  • 6James C,Ugo V,Casadevall N,et al.A JAK2 mutation in myeloproliferative disorders:pathogenesis and therapeutic and scientific prospects.Trends Mol Med,2005,11:546-554.
  • 7Goerttler PS,Steimle C,Marz E,et al.The Jak2V617F mutation,PRV-1 overexpression,and EEC formation define a similar cohort of MPD patients.Blood,2005,106:2862 -2864.
  • 8Kralovics R,Passamonti F,Buser AS,et al.A gain-of-function mutation of JAK2 in myeloproliferative disorders.N Engl J Med,2005,352:1779-1790.
  • 9Nelson ME,Steensma DP.JAK2 V617F in myeloid disorders:what do we know now,and where are we headed? Leuk Lymphoma,2006,47:177-194.
  • 10Prchal JT.Polycythemia vera and other primary polycythemias.Curr Opin Hematol,2005,12:112-116.

共引文献17

同被引文献11

  • 1朱平.骨髓增殖性疾病JAK2基因突变的临床意义[J].中华医学杂志,2006,86(32):2243-2245. 被引量:14
  • 2张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,1999:131-132.
  • 3Malcovati L, Della Porta MG, Pietra D, et al. Molecular and Clinical featurerefractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood, 2009, 114: 3538-3545.
  • 4Inga Gurevich, Raja Luthra, Sergej N. Konoplev, et al. Refractory anemia with ring sideroblasts associated with marked thrombocytosis. Am J Clin Pathol, 2011,135: 398-403.
  • 5林风茹,郭晓楠,任金海,等.恶性血液病诊治和疗效标准.2版.北京:人民军医出版社,2009:153-154.
  • 6Schmitt2Graeff AH, Teo SS, 01schewski M, et al. JAK2V617F mu2 ration status identifies subtypes of refractory anemia with ringed sider2 oblasts associated with marked thrombocytosis. Haematologica, 2008, 93: 34-40.
  • 7Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005, 106: 2162-2168.
  • 8Swerdllow SH,Campo E, Harris NL, et al. World Health Organi- zation classifica Tion of tumors pathology and geneties of tumors of haematopoietic and lymphoid tiessues[M]. 4th edition. Lyon IARC press: 2008.
  • 9肖志坚.骨髓增生异常综合征和骨髓增殖性肿瘤的诊断分型应重视的一些问题[J].中华血液学杂志,2010,31(4):217-218. 被引量:11
  • 10季鸥,沈群,林琳,章亚成,季建敏,吴萸,陈健一,朱光荣,孔祥图,夏雯,姜鹏君.血小板明显波动的难治性贫血伴环状铁粒幼细胞增多的临床与生物学特征[J].中国实验血液学杂志,2010,18(4):1036-1041. 被引量:4

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部